Iron out for nontransfused thalassemia. (se deschide o fereastră nouă)

Marks PW.

Sursă‎: Blood 2012;120(5):928-9.

Index‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (se deschide o fereastră nouă)

Iron overload in β-thalassemia intermedia: an emerging concern. (se deschide o fereastră nouă)

Musallam KM, Cappellini MD, Taher AT.

Sursă‎: Curr Opin Hematol 2013;20(3):187-92.

Index‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (se deschide o fereastră nouă)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (se deschide o fereastră nouă)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Sursă‎: Blood 2012;120(7):1531-2.

Index‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (se deschide o fereastră nouă)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (se deschide o fereastră nouă)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Sursă‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Index‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (se deschide o fereastră nouă)

Therapeutic roles of curcumin: lessons learned from clinical trials. (se deschide o fereastră nouă)

Gupta SC, Patchva S, Aggarwal BB.

Sursă‎: AAPS J 2013;15(1):195-218.

Index‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (se deschide o fereastră nouă)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (se deschide o fereastră nouă)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Sursă‎: J Med Assoc Thai 2012;95(1):29-36.

Index‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (se deschide o fereastră nouă)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (se deschide o fereastră nouă)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Sursă‎: Am J Hematol 2013;88(6):503-6.

Index‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (se deschide o fereastră nouă)